EXTRACORPOREAL HEART AND LUNG TREATMENTS
We offer extracorporeal membrane oxygenation (ECMO) treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop extracorporeal life support (ECLS) technologies that can be vital for the survival of critically ill patients.[1-3]
We provide solutions that combine both cardiac and pulmonary support on one single technological platform, the Xenios console. It supports gas exchange in the lungs and the cardiovascular system. ECMO thus provides physicians with crucial time for diagnosis and therapy.[1]
Xenios is part of Fresenius Medical Care, the world’s leading provider of products and services for people with renal diseases. As human organs are a mutually linked system, Fresenius Medical Care pursues a multi-organ support approach in Critical Care, drawing on its extensive expertise in extracorporeal blood treatment for acute kidney injury.
We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.
In our daily work, we share a passion for helping people.
For patients. Worldwide. Every day.
BY
YOUR
SIDE
GET IN TOUCH WITH US!
Find the right person for your topic with our contact form.
Heart & Lung Campus
Join, Learn, Care
Looking for further treatment and product information?
Join our Heart & Lung Campus to explore various e-learning modules, for example expert interviews, best-practice-cases, medical information, hands-on-tutorials and priming instructions.
On demand, 24 hours a day, 7 days a week – whenever you need it.
News
News
ISICEM Congress 2026
Thanks a lot for a fantastic experience at the 45th ISICEM Congress 2026 in Brussels. We appreciate all the meaningful discussions, valuable exchanges, and new connections made during the event. We hope to see you at future events!
News
SWAAC ELSO 2026
Thanks for a great SWAAC ELSO 2026 Conference! We shared new insights, had great conversations and enjoyed spending time with you in Chennai. See you next year!
Congress participation 2026
📅 Mark your calendars! We are very excited to announce our participation in the following congresses in 2026: • SWAAC ELSO in Chennai, 05-08 February • DGTHG in Cologne, 21-23 February • ISICEM in Brussels, 17-20 March • Nordic Light on ECLS in Stockholm, 25-27 March • EuroELSO in Dublin, 06-09 May • ESPNIC in Malta, ...
Events
05. – 08. May
EuroELSO Congress 2025 in Dublin
14th EuroELSO (European Extracorporeal Life Support Organization) Congress
https://euroelso-congress.com/
Venue
RDS (Royal Dublin Society) Venue in Dublin
16. – 19. June
ESPNIC 2026 in Valletta
35th International Congress of European Society of Paediatric and Neonatal Intensive Care (ESPNIC) 2026
https://www.mcascientificevents.eu/espnic/
Venue
Mediterranean Conference Centre, Valletta
07. – 10. October
EACTS 2026 in Barcelona
40th EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting
Venue
International Convention Centre, Barcelona
10. – 14. October
ESICM LIVES 2026 in Lisbon
39th ESICM's (European Society Of Intensive Care Medicine) annual congress - LIVES
https://www.esicm.org/events/39th-annual-congress-lisbon/
Venue
CCL, Congress Centre, Lisbon
[1] ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Extracorporeal Life Support Organization, Version 1.4 August 2017, Ann Arbor, MI, USA
[2] Peek, G. et al. (2009). Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet, 374(9698), 1351–1363
[3] Combes, A. et al. (2018). Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med, 378(21), 1965–1975